TransDigm Group Inc (TDG) reports strong fiscal performance with a $90 per share special dividend and strategic capital allocation, despite facing OEM and defense market headwinds.
31 分钟on MSN
Aethlon Medical signals expanded Australian oncology enrollment strategy while operating ...
Q2 2026 Management View CEO James Frakes opened the call highlighting progress on the Australian oncology trial and ongoing alignment of resources with strategic priorities. "As of September 30, 2025, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果